Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Mersana Therapeutics buy Citigroup Inc.

Mersana Therapeutics
Start price
€2.40
15.11.24 / 50%
Target price
€4.74
15.11.25
Performance (%)
-89.06%
End price
-
16.11.25
Summary
This prediction is currently being closed. The BUY prediction by Citigroup_Inc_ for Mersana Therapeutics is performing very badly with a performance of -89.06%. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Mersana Therapeutics - - -
iShares Core DAX® 1.604% -7.448% 3.039%
iShares Nasdaq 100 -0.734% -1.864% 15.425%
iShares Nikkei 225® 1.296% -6.795% 34.306%
iShares S&P 500 -0.394% -2.336% 9.907%

Comments by Citigroup_Inc_ for this prediction

In the thread Mersana Therapeutics diskutieren
Prediction Buy
Perf. (%) -89.06%
Target price 4.738
Change
Ends at 15.11.25

Mersana Therapeutics, Inc. (NASDAQ: MRSN) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $5.00 price target on the stock.
Ratings data for MRSN provided by MarketBeat

Citigroup Inc. 
0
Report Share
15.11.24
In the thread Trading Mersana Therapeutics
Prediction Buy
Perf. (%) -89.06%
Target price 4.738
Change
Ends at 15.11.25

Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten

Citigroup Inc. 
0
Report Share
16.11.25

Stopped prediction by Citigroup_Inc_ for Mersana Therapeutics

buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€1.34
27.08.24
€4.48
27.08.25
-84.11%
28.08.25

Citigroup Inc. 
27.08.24 50%
buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€1.71
04.12.23
€4.61
04.12.24
25.26%
05.12.24

Citigroup Inc. 
04.12.23 50%